{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:33Z","timestamp":1791910893797,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,23]]},"DOI":"10.7759\/cureus.72192","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T12:24:12Z","timestamp":1729686252000},"source":"Crossref","is-referenced-by-count":2,"title":["Reviewing the Impact of Maternal Opioid Use Disorder on Fetal Development and Long-Term Pediatric Health Outcomes"],"prefix":"10.7759","author":[{"given":"Manahil","family":"Asad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia T","family":"Bonner-Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Aldoohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neisha","family":"Ghanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Attia Hussein Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Venkatraj Srividya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preanka","family":"Devadas Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeza","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics","volume":"90","author":"Jamison RN","year":"2015","unstructured":"Jamison RN, Mao J. Opioid analgesics. Mayo Clin Proc. 2015, 90:957-68. 10.1016\/j.mayocp.2015.04.010","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: a common substrate in drug addiction","volume":"108","author":"Trigo JM","year":"2010","unstructured":"Trigo JM, Martin-Garc\u00eda E, Berrendero F, Robledo P, Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 2010, 108:183-94. 10.1016\/j.drugalcdep.2009.10.011","journal-title":"Drug Alcohol Depend"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.148","article-title":"Mechanism of opioid addiction and its intervention therapy: focusing on the reward circuitry and mu-opioid receptor","volume":"3","author":"Zhang JJ","year":"2022","unstructured":"Zhang JJ, Song CG, Dai JM, Li L, Yang XM, Chen ZN. Mechanism of opioid addiction and its intervention therapy: focusing on the reward circuitry and mu-opioid receptor. MedComm (2020). 2022, 3:e148. 10.1002\/mco2.148","journal-title":"MedComm (2020)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3491-11.2011","article-title":"Distinct mechanisms underlying pronociceptive effects of opioids","volume":"31","author":"Heinl C","year":"2011","unstructured":"Heinl C, Drdla-Schutting R, Xanthos DN, Sandk\u00fchler J. Distinct mechanisms underlying pronociceptive effects of opioids. J Neurosci. 2011, 31:16748-56. 10.1523\/JNEUROSCI.3491-11.2011","journal-title":"J Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06370-2","article-title":"Opioid withdrawal: role in addiction and neural mechanisms","volume":"240","author":"Monroe SC","year":"2023","unstructured":"Monroe SC, Radke AK. Opioid withdrawal: role in addiction and neural mechanisms. Psychopharmacology (Berl). 2023, 240:1417-33. 10.1007\/s00213-023-06370-2","journal-title":"Psychopharmacology (Berl)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1403326","article-title":"Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology","volume":"18","author":"Dwivedi I","year":"2024","unstructured":"Dwivedi I, Haddad GG. Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology. Front Cell Neurosci. 2024, 18:1403326. 10.3389\/fncel.2024.1403326","journal-title":"Front Cell Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai AH","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA. 2021, 325:146-55. 10.1001\/jama.2020.24991","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight SC","year":"2018","unstructured":"Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018, 67:845-9. 10.15585\/mmwr.mm6731a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","article-title":"Opioid prescription claims among women of reproductive age--United States, 2008-2012","volume":"64","author":"Ailes EC","year":"2015","unstructured":"Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA. Opioid prescription claims among women of reproductive age--United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015, 64:37-41.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/apa.17198","article-title":"Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth","volume":"113","author":"Kanervo M","year":"2024","unstructured":"Kanervo M, Luoto L, Tupola S, Nikkola E, Kahila H, Rantakari K. Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth. Acta Paediatr. 2024, 113:1579-91. 10.1111\/apa.17198","journal-title":"Acta Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/dev.22378","article-title":"A review of the literature: how does prenatal opioid exposure impact placental health and fetal brain development?","volume":"65","author":"Humphries A","year":"2023","unstructured":"Humphries A, Simcox K, Howell B. A review of the literature: how does prenatal opioid exposure impact placental health and fetal brain development?. Dev Psychobiol. 2023, 65:e22378. 10.1002\/dev.22378","journal-title":"Dev Psychobiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2019.11.005","article-title":"Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis","volume":"20","author":"Lee SJ","year":"2020","unstructured":"Lee SJ, Bora S, Austin NC, Westerman A, Henderson JM. Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis. Acad Pediatr. 2020, 20:308-18. 10.1016\/j.acap.2019.11.005","journal-title":"Acad Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009234.pub2","article-title":"Pain management for women in labour: an overview of systematic reviews","volume":"2012","author":"Jones L","year":"2012","unstructured":"Jones L, Othman M, Dowswell T, et al.. Pain management for women in labour: an overview of systematic reviews. Cochrane Database Syst Rev. 2012, 2012:CD009234. 10.1002\/14651858.CD009234.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2022.10.015","article-title":"Opioids and opioid use disorder in pregnancy","volume":"50","author":"Sanjanwala AR","year":"2023","unstructured":"Sanjanwala AR, Lim G, Krans EE. Opioids and opioid use disorder in pregnancy. Obstet Gynecol Clin North Am. 2023, 50:229-40. 10.1016\/j.ogc.2022.10.015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref15","unstructured":"Testimony to Congress | National Institute on Drug Abuse. National Institute on Drug Abuse. (2024). Accessed. May 23, 2024: https:\/\/www.drugabuse.gov\/about-nida\/legislative-activities\/testimony-to-congress\/2016\/americas-addiction-to-opioids-...."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000553378.44766.1d","article-title":"Opioid use disorder during pregnancy: an overview","volume":"32","author":"Carter LC","year":"2019","unstructured":"Carter LC, Read MA, Read L, Nicholas JS, Schmidt E. Opioid use disorder during pregnancy: an overview. JAAPA. 2019, 32:20-4. 10.1097\/01.JAA.0000553378.44766.1d","journal-title":"JAAPA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-024-01882-x","article-title":"Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022","volume":"44","author":"Dudley J","year":"2024","unstructured":"Dudley J, Gabrielson SM, O'Connor AB, Ahrens KA. Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022. J Perinatol. 2024, 44:1104-10. 10.1038\/s41372-024-01882-x","journal-title":"J Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2022.07.008","article-title":"Epidemiology of opioid use in pregnancy","volume":"85","author":"Cook JL","year":"2022","unstructured":"Cook JL. Epidemiology of opioid use in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2022, 85:12-7. 10.1016\/j.bpobgyn.2022.07.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard CS","year":"2011","unstructured":"Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011, 204:314.e1-11. 10.1016\/j.ajog.2010.12.039","journal-title":"Am J Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick SW","year":"2015","unstructured":"Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015, 35:650-5. 10.1038\/jp.2015.36","journal-title":"J Perinatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03563-8","article-title":"Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression","volume":"97","author":"Baldo BA","year":"2023","unstructured":"Baldo BA. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Arch Toxicol. 2023, 97:2575-85. 10.1007\/s00204-023-03563-8","journal-title":"Arch Toxicol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1110-4","article-title":"Opioid use in pregnancy","volume":"21","author":"Tobon AL","year":"2019","unstructured":"Tobon AL, Habecker E, Forray A. Opioid use in pregnancy. Curr Psychiatry Rep. 2019, 21:118. 10.1007\/s11920-019-1110-4","journal-title":"Curr Psychiatry Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske M","year":"2021","unstructured":"Piske M, Homayra F, Min JE, et al.. Opioid use disorder and perinatal outcomes. Pediatrics. 2021, 148:10.1542\/peds.2021-050279","journal-title":"Pediatrics"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000979","article-title":"Explaining racial-ethnic disparities in the receipt of medication for opioid use disorder during pregnancy","volume":"16","author":"Gao YA","year":"2022","unstructured":"Gao YA, Drake C, Krans EE, Chen Q, Jarlenski MP. Explaining racial-ethnic disparities in the receipt of medication for opioid use disorder during pregnancy. J Addict Med. 2022, 16:e356-65. 10.1097\/ADM.0000000000000979","journal-title":"J Addict Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28588","article-title":"Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns","volume":"5","author":"Esposito DB","year":"2022","unstructured":"Esposito DB, Huybrechts KF, Werler MM, Straub L, Hern\u00e1ndez-D\u00edaz S, Mogun H, Bateman BT. Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns. JAMA Netw Open. 2022, 5:e2228588. 10.1001\/jamanetworkopen.2022.28588","journal-title":"JAMA Netw Open"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.02.011","article-title":"The physiological role of pre- and postsynaptic GABA(B) receptors in membrane excitability and synaptic transmission of neurons in the rat's dorsal cortex of the inferior colliculus","volume":"160","author":"Sun H","year":"2009","unstructured":"Sun H, Wu SH. The physiological role of pre- and postsynaptic GABA(B) receptors in membrane excitability and synaptic transmission of neurons in the rat's dorsal cortex of the inferior colliculus. Neuroscience. 2009, 160:198-211. 10.1016\/j.neuroscience.2009.02.011","journal-title":"Neuroscience"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10997","article-title":"Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation","volume":"469","author":"Stumm RK","year":"2004","unstructured":"Stumm RK, Zhou C, Schulz S, H\u00f6llt V. Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. J Comp Neurol. 2004, 469:107-18. 10.1002\/cne.10997","journal-title":"J Comp Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0074-7742(08)60666-2","article-title":"Endogenous opioid regulation of hippocampal function","volume":"145","author":"Simmons ML","year":"1996","unstructured":"Simmons ML, Chavkin C. Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol. 1996, 145:96. 10.1016\/s0074-7742(08)60666-2","journal-title":"Int Rev Neurobiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2021.107002","article-title":"Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination","volume":"86","author":"Velasco B","year":"2021","unstructured":"Velasco B, Mohamed E, Sato-Bigbee C. Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination. Neurotoxicol Teratol. 2021, 86:107002. 10.1016\/j.ntt.2021.107002","journal-title":"Neurotoxicol Teratol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000365074","article-title":"The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination","volume":"36","author":"Vestal-Laborde AA","year":"2014","unstructured":"Vestal-Laborde AA, Eschenroeder AC, Bigbee JW, Robinson SE, Sato-Bigbee C. The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination. Dev Neurosci. 2014, 36:409-21. 10.1159\/000365074","journal-title":"Dev Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.254219","article-title":"In utero exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome","volume":"370","author":"Griffin BA","year":"2019","unstructured":"Griffin BA, Caperton CO, Russell LN, et al.. In utero exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome. J Pharmacol Exp Ther. 2019, 370:9-17. 10.1124\/jpet.118.254219","journal-title":"J Pharmacol Exp Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)90332-9","article-title":"Characterization and down-regulation of opiate receptors in aggregating fetal rat brain cells","volume":"304","author":"Lenoir D","year":"1984","unstructured":"Lenoir D, Barg J, Simantov R. Characterization and down-regulation of opiate receptors in aggregating fetal rat brain cells. Brain Res. 1984, 304:285-90. 10.1016\/0006-8993(84)90332-9","journal-title":"Brain Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000111918","article-title":"Developmental profile of kappa, mu and delta opioid receptors in the rat and guinea pig cerebellum","volume":"11","author":"Barg J","year":"1989","unstructured":"Barg J, Simantov R. Developmental profile of kappa, mu and delta opioid receptors in the rat and guinea pig cerebellum. Dev Neurosci. 1989, 11:428-34. 10.1159\/000111918","journal-title":"Dev Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0128","article-title":"Prenatal opioid exposure: neurodevelopmental consequences and future research priorities","volume":"144","author":"Conradt E","year":"2019","unstructured":"Conradt E, Flannery T, Aschner JL, et al.. Prenatal opioid exposure: neurodevelopmental consequences and future research priorities. Pediatrics. 2019, 144:10.1542\/peds.2019-0128","journal-title":"Pediatrics"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0514","article-title":"Cognitive and behavioral impact on children exposed to opioids during pregnancy","volume":"144","author":"Larson JJ","year":"2019","unstructured":"Larson JJ, Graham DL, Singer LT, et al.. Cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics. 2019, 144:10.1542\/peds.2019-0514","journal-title":"Pediatrics"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082262","article-title":"Depression-like effect of prenatal buprenorphine exposure in rats","volume":"8","author":"Hung CJ","year":"2013","unstructured":"Hung CJ, Wu CC, Chen WY, et al.. Depression-like effect of prenatal buprenorphine exposure in rats. PLoS One. 2013, 8:e82262. 10.1371\/journal.pone.0082262","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/nature01047","article-title":"L23 protein functions as a chaperone docking site on the ribosome","volume":"419","author":"Kramer G","year":"2002","unstructured":"Kramer G, Rauch T, Rist W, et al.. L23 protein functions as a chaperone docking site on the ribosome. Nature. 2002, 419:171-4. 10.1038\/nature01047","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04190.x","article-title":"Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells","volume":"965","author":"Oliveira MT","year":"2002","unstructured":"Oliveira MT, Rego AC, Morgadinho MT, Macedo TR, Oliveira CR. Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Ann N Y Acad Sci. 2002, 965:487-96. 10.1111\/j.1749-6632.2002.tb04190.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0119-22.2022","article-title":"Prenatal opioid exposure impairs endocannabinoid and glutamate transmission in the dorsal striatum","volume":"9","author":"Grecco GG","year":"2022","unstructured":"Grecco GG, Mu\u00f1oz B, Di Prisco GV, et al.. Prenatal opioid exposure impairs endocannabinoid and glutamate transmission in the dorsal striatum. eNeuro. 2022, 9:10.1523\/ENEURO.0119-22.2022","journal-title":"eNeuro"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.02.079","article-title":"Variants in the RAB3A gene are not associated with mental retardation in the Chinese population","volume":"401","author":"Sun Y","year":"2006","unstructured":"Sun Y, Zhang F, Gao J, et al.. Variants in the RAB3A gene are not associated with mental retardation in the Chinese population. Neurosci Lett. 2006, 401:114-8. 10.1016\/j.neulet.2006.02.079","journal-title":"Neurosci Lett"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2009.02.005","article-title":"Baicalin administration is effective in positive regulation of twenty-four ischemia\/reperfusion-related proteins identified by a proteomic study","volume":"54","author":"Zhang Z","year":"2009","unstructured":"Zhang Z, Wu R, Li P, et al.. Baicalin administration is effective in positive regulation of twenty-four ischemia\/reperfusion-related proteins identified by a proteomic study. Neurochem Int. 2009, 54:488-96. 10.1016\/j.neuint.2009.02.005","journal-title":"Neurochem Int"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2013.12.001","article-title":"Prenatal buprenorphine exposure decreases neurogenesis in rats","volume":"225","author":"Wu CC","year":"2014","unstructured":"Wu CC, Hung CJ, Shen CH, et al.. Prenatal buprenorphine exposure decreases neurogenesis in rats. Toxicol Lett. 2014, 225:92-101. 10.1016\/j.toxlet.2013.12.001","journal-title":"Toxicol Lett"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23632","article-title":"Rescue of deficient amygdala tonic \u03b3-aminobutyric acidergic currents in the Fmr-\/y mouse model of fragile X syndrome by a novel \u03b3-aminobutyric acid type A receptor-positive allosteric modulator","volume":"94","author":"Martin BS","year":"2016","unstructured":"Martin BS, Martinez-Botella G, Loya CM, et al.. Rescue of deficient amygdala tonic \u03b3-aminobutyric acidergic currents in the Fmr-\/y mouse model of fragile X syndrome by a novel \u03b3-aminobutyric acid type A receptor-positive allosteric modulator. J Neurosci Res. 2016, 94:568-78. 10.1002\/jnr.23632","journal-title":"J Neurosci Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas PW","year":"2009","unstructured":"Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009, 10:561-72. 10.1038\/nrn2515","journal-title":"Nat Rev Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.46","article-title":"New medications for drug addiction hiding in glutamatergic neuroplasticity","volume":"16","author":"Kalivas PW","year":"2011","unstructured":"Kalivas PW, Volkow ND. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011, 16:974-86. 10.1038\/mp.2011.46","journal-title":"Mol Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobeha.2018.06.005","article-title":"Sex steroid hormones and differential risk for eating pathology: a review of genetic and phenotypic effects across development","volume":"23","author":"Culbert K","year":"2018","unstructured":"Culbert K, Sisk C, Klump K. Sex steroid hormones and differential risk for eating pathology: a review of genetic and phenotypic effects across development. Curr Opin Behav Sci. 2018, 23:124-30. 10.1016\/j.cobeha.2018.06.005","journal-title":"Curr Opin Behav Sci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077664","article-title":"Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea","volume":"385","author":"Kang J","year":"2024","unstructured":"Kang J, Kim HJ, Kim T, et al.. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ. 2024, 385:e077664. 10.1136\/bmj-2023-077664","journal-title":"BMJ"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.01.013","article-title":"Adverse neurodevelopmental outcome of infants exposed to opiate in-utero","volume":"84","author":"Hunt RW","year":"2008","unstructured":"Hunt RW, Tzioumi D, Collins E, Jeffery HE. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev. 2008, 84:29-35. 10.1016\/j.earlhumdev.2007.01.013","journal-title":"Early Hum Dev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2008.20.3.292","article-title":"Preliminary evidence for sensitive periods in the effect of childhood sexual abuse on regional brain development","volume":"20","author":"Andersen SL","year":"2008","unstructured":"Andersen SL, Tomada A, Vincow ES, Valente E, Polcari A, Teicher MH. Preliminary evidence for sensitive periods in the effect of childhood sexual abuse on regional brain development. J Neuropsychiatry Clin Neurosci. 2008, 20:292-301. 10.1176\/jnp.2008.20.3.292","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.03.043","article-title":"Childhood metabolic biomarkers are associated with performance on cognitive tasks in young children","volume":"211","author":"Shapiro AL","year":"2019","unstructured":"Shapiro AL, Wilkening G, Aalborg J, Ringham BM, Glueck DH, Tregellas JR, Dabelea D. Childhood metabolic biomarkers are associated with performance on cognitive tasks in young children. J Pediatr. 2019, 211:92-7. 10.1016\/j.jpeds.2019.03.043","journal-title":"J Pediatr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/add.14155","article-title":"Corrigendum","volume":"113","year":"2018","unstructured":"Corrigendum. Addiction. 2018, 113.581. 10.1111\/add.14155","journal-title":"Addiction"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2010.546778","article-title":"Nonverbal learning disabilities: a critical review","volume":"17","author":"Spreen O","year":"2011","unstructured":"Spreen O. Nonverbal learning disabilities: a critical review. Child Neuropsychol. 2011, 17:418-43. 10.1080\/09297049.2010.546778","journal-title":"Child Neuropsychol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2021.107000","article-title":"Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use","volume":"86","author":"Labella MH","year":"2021","unstructured":"Labella MH, Eiden RD, Tabachnick AR, Sellers T, Dozier M. Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use. Neurotoxicol Teratol. 2021, 86:107000. 10.1016\/j.ntt.2021.107000","journal-title":"Neurotoxicol Teratol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.08.014","article-title":"Association between utilization of quitline services and probability of tobacco abstinence in low-income smokers","volume":"71","author":"Bernstein SL","year":"2016","unstructured":"Bernstein SL, Weiss JM, Toll B, Zbikowski SM. Association between utilization of quitline services and probability of tobacco abstinence in low-income smokers. J Subst Abuse Treat. 2016, 71:58-62. 10.1016\/j.jsat.2016.08.014","journal-title":"J Subst Abuse Treat"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8256","article-title":"Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018","volume":"3","author":"Corsi DJ","year":"2020","unstructured":"Corsi DJ, Hsu H, Fell DB, Wen SW, Walker M. Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018. JAMA Netw Open. 2020, 3:e208256. 10.1001\/jamanetworkopen.2020.8256","journal-title":"JAMA Netw Open"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2015.1108395","article-title":"Timed performance weaknesses on computerized tasks in pediatric brain tumor survivors: a comparison with sibling controls","volume":"23","author":"de Ruiter MA","year":"2017","unstructured":"de Ruiter MA, Grootenhuis MA, van Mourik R, et al.. Timed performance weaknesses on computerized tasks in pediatric brain tumor survivors: a comparison with sibling controls. Child Neuropsychol. 2017, 23:208-27. 10.1080\/09297049.2015.1108395","journal-title":"Child Neuropsychol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14117","article-title":"Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis","volume":"61","author":"Monnelly VJ","year":"2019","unstructured":"Monnelly VJ, Hamilton R, Chappell FM, Mactier H, Boardman JP. Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis. Dev Med Child Neurol. 2019, 61:750-60. 10.1111\/dmcn.14117","journal-title":"Dev Med Child Neurol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.7025","article-title":"Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis","volume":"2","author":"Yeoh SL","year":"2019","unstructured":"Yeoh SL, Eastwood J, Wright IM, Morton R, Melhuish E, Ward M, Oei JL. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open. 2019, 2:e197025. 10.1001\/jamanetworkopen.2019.7025","journal-title":"JAMA Netw Open"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14808","article-title":"Prenatal methadone exposure and child developmental outcomes in 2-year-old children","volume":"63","author":"Levine TA","year":"2021","unstructured":"Levine TA, Davie-Gray A, Kim HM, Lee SJ, Woodward LJ. Prenatal methadone exposure and child developmental outcomes in 2-year-old children. Dev Med Child Neurol. 2021, 63:1114-22. 10.1111\/dmcn.14808","journal-title":"Dev Med Child Neurol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31827feea4","article-title":"Neonatal abstinence syndrome: treatment and pediatric outcomes","volume":"56","author":"Logan BA","year":"2013","unstructured":"Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol. 2013, 56:186-92. 10.1097\/GRF.0b013e31827feea4","journal-title":"Clin Obstet Gynecol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkac037","article-title":"Can umbilical cord and meconium results be directly compared? Analytical approach matters","volume":"47","author":"Pandya V","year":"2023","unstructured":"Pandya V, Wilker C, McMillin GA. Can umbilical cord and meconium results be directly compared? Analytical approach matters. J Anal Toxicol. 2023, 47:96-105. 10.1093\/jat\/bkac037","journal-title":"J Anal Toxicol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-022-00726-5","article-title":"Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study","volume":"114","author":"Plouffe R","year":"2023","unstructured":"Plouffe R, Grywacheski V, Luo W, Nelson C, Orpana H. Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study. Can J Public Health. 2023, 114:277-86. 10.17269\/s41997-022-00726-5","journal-title":"Can J Public Health"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14497","article-title":"Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder","volume":"102","author":"Kanervo MM","year":"2023","unstructured":"Kanervo MM, Tupola SJ, Nikkola EM, Rantakari KM, Kahila HK. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder. Acta Obstet Gynecol Scand. 2023, 102:313-22. 10.1111\/aogs.14497","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13677","article-title":"Management and monitoring of opioid use in pregnancy","volume":"99","author":"Rausgaard NL","year":"2020","unstructured":"Rausgaard NL, Ibsen IO, J\u00f8rgensen JS, Lamont RF, Ravn P. Management and monitoring of opioid use in pregnancy. Acta Obstet Gynecol Scand. 2020, 99:7-15. 10.1111\/aogs.13677","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104342","article-title":"Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S","volume":"126","author":"Curran L","year":"2024","unstructured":"Curran L, Manuel J. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S. Int J Drug Policy. 2024, 126:104342. 10.1016\/j.drugpo.2024.104342","journal-title":"Int J Drug Policy"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurkewich EL","year":"2014","unstructured":"Mozurkewich EL, Rayburn WF. Buprenorphine and methadone for opioid addiction during pregnancy. Obstet Gynecol Clin North Am. 2014, 41:241-53. 10.1016\/j.ogc.2014.02.005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones HE","year":"2012","unstructured":"Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012, 72:747-57. 10.2165\/11632820-000000000-00000","journal-title":"Drugs"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series","volume":"96","author":"Kakko J","year":"2008","unstructured":"Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008, 96:69-78. 10.1016\/j.drugalcdep.2008.01.025","journal-title":"Drug Alcohol Depend"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/add.14192","article-title":"Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway","volume":"113","author":"Nechansk\u00e1 B","year":"2018","unstructured":"Nechansk\u00e1 B, Mrav\u010d\u00edk V, Skurtveit S, Lund IO, Gabrhel\u00edk R, Engeland A, Handal M. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 2018, 113:1286-94. 10.1111\/add.14192","journal-title":"Addiction"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand GK","year":"2013","unstructured":"Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjark\u00f8 L, Ravndal E. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009. Drug Alcohol Depend. 2013, 127:200-6. 10.1016\/j.drugalcdep.2012.07.001","journal-title":"Drug Alcohol Depend"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2012.03.008","article-title":"Treatment of opioid dependence in the setting of pregnancy","volume":"35","author":"Young JL","year":"2012","unstructured":"Young JL, Martin PR. Treatment of opioid dependence in the setting of pregnancy. Psychiatr Clin North Am. 2012, 35:441-60. 10.1016\/j.psc.2012.03.008","journal-title":"Psychiatr Clin North Am"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2014.08.009","article-title":"Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome","volume":"39","author":"Winhusen T","year":"2014","unstructured":"Winhusen T, Wilder C, Wexelblatt SL, et al.. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Contemp Clin Trials. 2014, 39:158-65. 10.1016\/j.cct.2014.08.009","journal-title":"Contemp Clin Trials"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1177\/1745506520952006","article-title":"Hospital care for opioid use disorder in pregnancy: challenges and opportunities identified from a Minnesota survey","volume":"16","author":"Dopp A","year":"2020","unstructured":"Dopp A, Zabel Thornton M, Kozhimannil K, Jones CW, Greenfield B. Hospital care for opioid use disorder in pregnancy: challenges and opportunities identified from a Minnesota survey. Womens Health (Lond). 2020, 16:1745506520952006. 10.1177\/1745506520952006","journal-title":"Womens Health (Lond)"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100137","article-title":"Consensus guidelines and state policies: the gap between principle and practice at the intersection of substance use and pregnancy","volume":"2","author":"Faherty LJ","year":"2020","unstructured":"Faherty LJ, Stein BD, Terplan M. Consensus guidelines and state policies: the gap between principle and practice at the intersection of substance use and pregnancy. Am J Obstet Gynecol MFM. 2020, 2:100137. 10.1016\/j.ajogmf.2020.100137","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6836a1","article-title":"State strategies to address opioid use disorder among pregnant and postpartum women and infants prenatally exposed to substances, including infants with neonatal abstinence syndrome","volume":"68","author":"Kroelinger CD","year":"2019","unstructured":"Kroelinger CD, Rice ME, Cox S, et al.. State strategies to address opioid use disorder among pregnant and postpartum women and infants prenatally exposed to substances, including infants with neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep. 2019, 68:777-83. 10.15585\/mmwr.mm6836a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-023-03792-4","article-title":"Public health approaches to perinatal substance use: an overview of strategic directions","volume":"27","author":"Echols A","year":"2023","unstructured":"Echols A, Collins S, Akbarali S, Dronamraju R, Uesugi K. Public health approaches to perinatal substance use: an overview of strategic directions. Matern Child Health J. 2023, 27:1-4. 10.1007\/s10995-023-03792-4","journal-title":"Matern Child Health J"},{"key":"ref77","unstructured":"Canadian Opioid Use Disorder Guideline. (2021). Accessed. July 5, 2024: https:\/\/www.camh.ca\/en\/health-info\/guides-and-publications\/canadian-opioid-use-disorder-guideline."},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6609a2","article-title":"CDC Grand Rounds: public health strategies to prevent neonatal abstinence syndrome","volume":"66","author":"Ko JY","year":"2017","unstructured":"Ko JY, Wolicki S, Barfield WD, et al.. CDC Grand Rounds: public health strategies to prevent neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep. 2017, 66:242-5. 10.15585\/mmwr.mm6609a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref79","unstructured":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. (2018). Accessed. May 16, 2024: https:\/\/store.samhsa.gov\/home."},{"key":"ref80","unstructured":"Addiction and Substance Misuse Reports and Publications. HHS.gov. (2024). Accessed. March 18, 2024: https:\/\/www.hhs.gov\/surgeongeneral\/reports-and-publications\/addiction-and-substance-misuse\/index.html."},{"key":"ref81","unstructured":"Final report. opioid use, misuse, and overdose in women. (2017). Accessed: March 24, 2024: https:\/\/www.womenshealth.gov\/files\/documents\/final-report-opioid-508.pdf.."},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham A","year":"2022","unstructured":"Cheetham A, Picco L, Barnett A, Lubman DI, Nielsen S. The impact of stigma on people with opioid use disorder, opioid treatment, and policy. Subst Abuse Rehabil. 2022, 13:1-12. 10.2147\/SAR.S304566","journal-title":"Subst Abuse Rehabil"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.154864","article-title":"Maternal methadone dose, placental methadone concentrations, and neonatal outcomes","volume":"57","author":"de Castro A","year":"2011","unstructured":"de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin Chem. 2011, 57:449-58. 10.1373\/clinchem.2010.154864","journal-title":"Clin Chem"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2012.10.011","article-title":"Review: transport across the placenta of mice and women","volume":"34 Suppl","author":"Dilworth MR","year":"2013","unstructured":"Dilworth MR, Sibley CP. Review: transport across the placenta of mice and women. Placenta. 2013, 34 Suppl:S34-9. 10.1016\/j.placenta.2012.10.011","journal-title":"Placenta"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113621","article-title":"Prenatal opioid exposure and vulnerability to future substance use disorders in offspring","volume":"339","author":"Abu Y","year":"2021","unstructured":"Abu Y, Roy S. Prenatal opioid exposure and vulnerability to future substance use disorders in offspring. Exp Neurol. 2021, 339:113621. 10.1016\/j.expneurol.2021.113621","journal-title":"Exp Neurol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.12.007","article-title":"Addiction biomarkers: dimensional approaches to understanding addiction","volume":"24","author":"Kwako LE","year":"2018","unstructured":"Kwako LE, Bickel WK, Goldman D. Addiction biomarkers: dimensional approaches to understanding addiction. Trends Mol Med. 2018, 24:121-8. 10.1016\/j.molmed.2017.12.007","journal-title":"Trends Mol Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2016.1201530","article-title":"The potential biomarkers of drug addiction: proteomic and metabolomics challenges","volume":"21","author":"Wang L","year":"2016","unstructured":"Wang L, Wu N, Zhao TY, Li J. The potential biomarkers of drug addiction: proteomic and metabolomics challenges. Biomarkers. 2016, 21:678-85. 10.1080\/1354750X.2016.1201530","journal-title":"Biomarkers"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-023-01613-8","article-title":"Comparing maternal substance use and perinatal outcomes before and during the COVID-19 pandemic","volume":"43","author":"Lien J","year":"2023","unstructured":"Lien J, Hayes T, Liu-Smith F, Rana D. Comparing maternal substance use and perinatal outcomes before and during the COVID-19 pandemic. J Perinatol. 2023, 43:664-9. 10.1038\/s41372-023-01613-8","journal-title":"J Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301571-reviewing-the-impact-of-maternal-opioid-use-disorder-on-fetal-development-and-long-term-pediatric-health-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T12:24:18Z","timestamp":1729686258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301571-reviewing-the-impact-of-maternal-opioid-use-disorder-on-fetal-development-and-long-term-pediatric-health-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":88,"URL":"https:\/\/doi.org\/10.7759\/cureus.72192","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,23]]}}}